Research / IR / Fundamental state Inspectable configuration
State dimensions Filing 0001140361-19-004014 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
61.87% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.94% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.53% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
13.24% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
19.48% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
37.64% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
16.47% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.89% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.10% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 26 states Self-history eligible
Dec 31, 2018 0/9 normalized Level 3 Mar 31, 2019 0/8 normalized Level 3 Jun 30, 2019 5/8 normalized Level 3 Sep 30, 2019 7/8 normalized Level 3 Dec 31, 2019 7/9 normalized Level 3 Mar 31, 2020 7/8 normalized Level 3 Jun 30, 2020 8/8 normalized Level 3 Sep 30, 2020 8/8 normalized Level 3 Mar 31, 2021 7/7 normalized Level 3 Jun 30, 2021 7/7 normalized Level 3 Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Sep 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 253.50%
Current 61.87%
Delta -191.63% Capex Intensity Increased
Previous 1.62%
Current 1.94%
Delta 0.32% Cash Generation Increased
Previous 15.06%
Current 16.53%
Delta 1.47% Growth Increased
Previous 6.11%
Current 13.24%
Delta 7.12% Inventory Pressure Decreased
Previous 79.81%
Current 19.48%
Delta -60.33% Margin Decreased
Previous 38.07%
Current 37.64%
Delta -0.43% Profitability Decreased
Previous 17.08%
Current 16.47%
Delta -0.61% Sbc Intensity Decreased
Previous 0.13%
Current 0.10%
Delta -0.03% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.